OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Clinical characteristics and therapy response in unresectable melanoma patients stage IIIB-IIID with in-transit and satellite metastases
Anne Zaremba, Manuel Philip, Jessica C. Hassel, et al.
European Journal of Cancer (2021) Vol. 152, pp. 139-154
Closed Access | Times Cited: 22

Showing 22 citing articles:

Understanding the Tumor Microenvironment in Melanoma Patients with In-Transit Metastases and Its Impacts on Immune Checkpoint Immunotherapy Responses
Jiabao Tian, Camelia Quek
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 8, pp. 4243-4243
Open Access | Times Cited: 7

The Diagnosis and Management of Cutaneous Metastases from Melanoma
Cosimo Di Raimondo, Flavia Lozzi, Pier Paolo Di Domenico, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 19, pp. 14535-14535
Open Access | Times Cited: 14

The efficacy of immune checkpoint blockade for melanoma in-transit with or without nodal metastases – A multicenter cohort study
Carl Jacob Holmberg, Lars Ny, Tina J. Hieken, et al.
European Journal of Cancer (2022) Vol. 169, pp. 210-222
Open Access | Times Cited: 21

Isolated hyperthermic perfusions for cutaneous melanoma in-transit metastasis of the limb and uveal melanoma metastasis to the liver
Anne Huibers, Danielle K. DePalo, Matthew Perez, et al.
Clinical & Experimental Metastasis (2023) Vol. 41, Iss. 4, pp. 447-456
Open Access | Times Cited: 12

Impact of electrochemotherapy in metastatic cutaneous melanoma: a contemporary systematic review and meta-analysis
Fausto Petrelli, Antonio Ghidini, Andrea Simioni, et al.
Acta Oncologica (2021) Vol. 61, Iss. 5, pp. 533-544
Closed Access | Times Cited: 22

Effects of the Introduction of Modern Immunotherapy on the Outcome of Isolated Limb Perfusion for Melanoma In-Transit Metastases
Carl Jacob Holmberg, Jan Mattsson, Roger Olofsson Bagge
Cancers (2023) Vol. 15, Iss. 2, pp. 472-472
Open Access | Times Cited: 9

European e-Delphi process to define expert consensus on electrochemotherapy treatment indications, procedural aspects, and quality indicators in melanoma
L Campana, Sofia Farronato, Jackie Hodgetts, et al.
British journal of surgery (2023) Vol. 110, Iss. 7, pp. 818-830
Open Access | Times Cited: 4

Treatment strategies with electrochemotherapy for limb in-transit melanoma: real-world outcomes from a European, retrospective, cohort study
L Campana, Francesca Tauceri, Joana Bártolo, et al.
European Journal of Surgical Oncology (2024), pp. 108740-108740
Closed Access | Times Cited: 1

Isolated Limb Perfusion and Immunotherapy in the Treatment of In-Transit Melanoma Metastases: Is It a Real Synergy?
Marco Rastrelli, Francesco Russano, Francesco Cavallin, et al.
Journal of Personalized Medicine (2024) Vol. 14, Iss. 5, pp. 442-442
Open Access | Times Cited: 1

Therapeutic Treatment Options for In-Transit Metastases from Melanoma
Francesco Russano, Marco Rastrelli, Luigi Dall’Olmo, et al.
Cancers (2024) Vol. 16, Iss. 17, pp. 3065-3065
Open Access | Times Cited: 1

Additive Intralesional Interleukin-2 Improves Progression-Free Survival in a Distinct Subgroup of Melanoma Patients with Prior Progression under Immunotherapy
David Rafei‐Shamsabadi, Saskia Lehr, Max Behrens, et al.
Cancers (2022) Vol. 14, Iss. 3, pp. 540-540
Open Access | Times Cited: 6

Management of In-Transit Metastases
Marcello Moro Queiroz, Eduardo Bertolli, Francisco Aparecido Belfort, et al.
Current Oncology Reports (2022) Vol. 24, Iss. 5, pp. 573-583
Closed Access | Times Cited: 3

Real-world outcomes with T-VEC in patients with anti-PD-1 resistant in-transit disease from melanoma and Merkel cell carcinoma
David Su, Madeline McNamara, Margaret A. Kaszycki, et al.
Surgical Oncology Insight (2024), pp. 100120-100120
Open Access

Great Debate: Limb Infusion for Melanoma: A Thing of the Past?
Kristen E. Rhodin, Douglas S. Tyler, Jonathan S. Zager, et al.
Annals of Surgical Oncology (2023) Vol. 30, Iss. 11, pp. 6319-6324
Closed Access | Times Cited: 1

Management of In-Transit Metastatic Melanoma
Matthew Perez, Jonathan S. Zager
Advances in Oncology (2023) Vol. 3, Iss. 1, pp. 29-36
Open Access | Times Cited: 1

Needle before Scalpel: Considering the Role of Intratumoral Therapy in Melanoma
T. Katz, Asad Javed, Jennifer G. Powers
Dermatologic Therapy (2024) Vol. 2024, Iss. 1
Open Access

Combinatorial Strategies for T Lymphocyte-Based Cancer Immunotherapy
Kristian M. Hargadon, James B. Wall
Springer eBooks (2022), pp. 1-40
Closed Access | Times Cited: 2

Page 1

Scroll to top